You’re on our free ad-supported tier. Upgrade to NewsNow Essentials for just £4/m now! Your favourite news platform, faster, slicker and ad free.You’re on our free tier. Get NewsNow Essentials at just £4/m now!. Faster, slicker and ad free.You’re on our free tier. Go ad free for just £4/m now!

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
AI
Business
Football
Sport
Entertainment
Tech
Science

"Scholar Rock"
Topics

Advertisement

Advertisement

"Scholar Rock"

Showing articles that match "Scholar Rock" in the headline

In the last 8 hours

Scholar Rock wins FDA approval for spinal muscle atrophy drug Boston Globe 14:38

Yesterday

Scholar Rock Bringing First SMA Add-On Treatment To US Patients, At $310,000 Net Cost Scrip Pharma Intelligence 22:54 Mon, 14 Sep

Strong-willed Isembyld: Scholar Rock prevails, FDA-OK’d in SMA BioWorld 21:44 Mon, 14 Sep

Advertisement

Advertisement

Scholar Rock Marks 'Defining Moment' with First Muscle-Targeted Treatment for Spinal Muscular Atrophy Benzinga 14:28 Mon, 14 Sep

Scholar Rock gets first drug approval as FDA okays Isembyld pharmaphorum 12:05 Mon, 14 Sep

Scholar Rock’s muscle-targeting SMA therapy Isemblyd lands FDA approval Pharmaceutical Technology 11:47 Mon, 14 Sep

Why Scholar Rock Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket Benzinga 10:55 Mon, 14 Sep

Saturday

STAT Plus: Scholar Rock wins FDA approval for first drug to target SMA muscle loss STAT 00:41 Sat, 12 Sep

Friday

Scholar Rock Announces FDA Approval of Isembyld™ (apitegromab-mstn), the First and Only Muscle-Targeted Treatment for Children and Adults with Spinal Muscular Atrophy (SMA) Business Wire (Press Release) 23:28 Fri, 11 Sep

Wednesday

Scholar Rock Holding (SRRK) After Fast Track News And A Tighter Valuation Debate Simply Wall St 21:22 Wed, 09 Sep

In the last month

Scholar Rock: FDA Grants Fast Track And Orphan Drug Designations To Apitegromab RTT News 13:51 Wed, 02 Sep

Scholar Rock Receives FDA Fast Track Designation for Apitegromab Facioscapulohumeral Muscular Dystrophy (Fshd) Program as Participant Dosing Commences in Phase 2 forge Trial Business Wire (Press Release) 13:02 Wed, 02 Sep

Scholar Rock Holding (SRRK) Stock Dropped, So What Is Behind The Latest Attention? Simply Wall St 09:17 Mon, 31 Aug

Scholar Rock to Present at Upcoming Investor Conferences Business Wire (Press Release) 13:05 Thu, 27 Aug

Scholar Rock (SRRK) Is Up 8.5% After De-Risking Apitegromab’s Global Filing Pathway - Has The Bull Case Changed? Simply Wall St 10:22 Mon, 24 Aug

Advertisement

Scholar Rock (SRRK) Stock Trades At A Premium As Its 8x Run Continues Simply Wall St 08:37 Sun, 23 Aug

Scholar Rock Provides Update on Global Apitegromab Regulatory Progress Across U.S., Europe, and Japan Business Wire (Press Release) 14:12 Fri, 21 Aug

Advertisement

My Local News

Advertisement

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Hot Topics Hot Topics
Climate Crisis
UK UK
World World
Business Business
Entertainment
Sport Sport
Football Football
AI AI
Technology Technology
Science Science
Lifestyle Lifestyle
Industry Sectors